Skip to content

To determine the half-maximal effective concentration (EC50) of ropivacaine for supra inguinal fascia iliaca compartment block (FICB) or pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve block (LFCN) in the patient with total hip arthroplasty

To determine the half-maximal effective concentration (EC50) of ropivacaine for supra inguinal fascia iliaca compartment block (FICB) or pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve block (LFCN) in the patient with total hip arthroplasty

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071319
Enrollment
Unknown
Registered
2023-05-11
Start date
2023-05-13
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observation on analgesia of the patient with proximal femur fractures who accepted total hiparthroplasty

Interventions

pericapsular nerve group (PENG) block with lateral femoral cutaneous nerve block (LFCN) group:PENG block : various concentrations of ropivacaine with 20mL volume LFCN:LFCN : various concentrations of
supra inguinal fascia iliaca compartment block (FICB) :FICB: various concentrations of ropivacaine with 30mL volume

Sponsors

Funing People's Hospital of Jiangsu Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: Gender is not limited, ASA grade I-III, aged 55-75 years, body mass index (BMI) 20-29kg / ?. Patients with normal intelligence, ability to understand and willing to participate in this study, and willing to sign informed consent.

Exclusion criteria

Exclusion criteria: Patients with severe cardiopulmonary function, liver and kidney dysfunction; Patients with allergic history of related drugs;the patient was not able or willing to cooperate with testing and assessments; Patients with a long history of gastric ulcer and gas-trorrhagia; Patients cannot tolerate a nerve block; Patients with a contraindication for puncture;Patients with a long history of painful diseases; Patients with a history of drug or alcohol dependence; Contraindications for general anaesthesia; Patients with severe cardiopulmonary function, liver and kidney dysfunction; Patients with high blood pressure, diabetes, mental disorders and mental disorders.

Design outcomes

Primary

MeasureTime frame
VAS Scoring;EC50 by sequential approach;

Secondary

MeasureTime frame
Demographic data;nerve block-related conditions;Resuscitation situations;Prognosis of the studied patients;Adverse effects;

Countries

China

Contacts

Public ContactDekun Yin

Funing People's Hospital of Jiangsu Province

153761717@qq.com+86 153 8054 6309

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026